Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)
Semaglutide: Bloodwork Guide
Recommended lab tests and biomarkers to monitor before, during, and after Semaglutide therapy. Testing schedules are based on clinical protocols and published monitoring guidelines.
Back to Semaglutide overviewBefore Starting (2 tests)
| Biomarker | Expected Effect | Retest |
|---|---|---|
| HbA1c | → normalizes | Once (baseline) |
| Fasting Glucose | → normalizes | Once (baseline) |
During Treatment (7 tests)
| Biomarker | Expected Effect | Retest |
|---|---|---|
| HbA1c | ↓ decreases | Every 12 weeks |
| Fasting Glucose | ↓ decreases | Every 4 weeks |
| Body Weight | ↓ decreases | Every 4 weeks |
| hs-CRP | ↓ decreases | Every 12 weeks |
| ALT/AST | → normalizes | Every 12 weeks |
| Lipid Panel | → normalizes | Every 12 weeks |
| Triglycerides | ↓ decreases | Every 12 weeks |